Professional Documents
Culture Documents
Fasdaklebebi
Fasdaklebebi
1 . 1 N90
Specifar pharm
2 . 5 N30
GMP
GMP
3 . 10 N30
GMP
GMP
4 . 500 N3 GMP
GMP
5 M SR . 2/500 N30
Handok Pharmaceuticals
6 M . 2/500 N30
Handok Pharmaceuticals
7 . 1 N30
Sanofi-Aventis (Italy)
8 . 2 N30
Sanofi-Aventis (Italy)
9 . 3 N30
Sanofi-Aventis (Italy)
10 . 4 N30
Sanofi-Aventis (Italy)
11 . 5 N30
Laboratoire Bailly-Creat
GMP
GMP
14 . 410 N60
Vitamer
15 . 50 N10
16 ..1.5 N30
Servier (France)
17 .10 N30
GMP
18 .2.5 N30
GMP
19 .5 N30
GMP
20 -H 5/25 N30
GMP
GMP
22 C .N10 . BAYER
Bayer Bitterfeld
23 . 0.1 N20
Bayer Bitterfeld
24 . 16 N28
25 . 32 N28
26 . 8 N28
27 . 10 N30
KRKA (Slovenia)
28 . 20 N30
KRKA (Slovenia)
29 . 40 N30
KRKA (Slovenia)
30 . 1 N14
GlaxoSmithkline (Eng)
31 N50
Takeda Gmbh
32 1.5
LDP-Laboratorios
58.40
7.40
13.70
15.10
27.39
25.90
4.18
6.05
9.40
10.45
44.57
16.40
24.70
99.00
9.00
18.70
10.50
7.90
8.80
15.10
14.70
5.61
6.20
68.31
89.54
56.10
13.75
16.50
35.97
15.70
73.00
14.08
43.15
5.17
9.56
10.54
19.11
18.07
3.22
4.36
7.26
6.72
32.93
11.04
16.63
73.15
6.28
12.59
7.33
5.51
6.14
10.54
10.26
3.92
4.33
50.47
66.16
41.45
8.47
10.62
27.76
11.60
53.94
9.83
26%
30%
30%
30%
30%
30%
23%
28%
23%
36%
26%
33%
33%
26%
30%
33%
30%
30%
30%
30%
30%
30%
30%
26%
26%
26%
38%
36%
23%
26%
26%
30%
33 - 5 . N30
Berlin-chemie (Germany)
34 -10 . N30
Berlin-chemie (Germany)
35 -20 . N30
Berlin-chemie (Germany)
36 Zok 25 N14
37 Zok 50 N30
40 . 24 N50
Abbot (Holland)
41 90 N56
42 8 N25
Berlin-chemie (Germany)
43 -P . 3,5.N10
Lek
44 . 500/2.5 N30
Merck Sante
45 . 500/5 N30
Merck Sante
46 . MR 30 N30 GMP
GMP
47 . .300 N100
Sanofi (France)
48 .500 N30
Sanofi (France)
49 . 500 N60
Servier (France)
50 MR . 60 N30
Servier (France)
51 . 0.5/0.4 N30
Catalent germany
52 .10 N20
Abbot (Holland)
53 H . 2.5 N30
GMP
54 . 5 N30
GMP
55 .10 N30
GMP
56 . 10 N20 GMP
GMP
GMP
58 -H .10./25 N20
KRKA (Slovenia)
59 XR . 500 N50
Abdi Ibrahim
60 XR . 750 N50
Abdi Ibrahim
61 . 500 N50
Abdi Ibrahim
62 . 1000 N50
Abdi Ibrahim
63 N 300 N30
A.Nattermann
64 . 150 N10
Bristol-Myers(France)
4.15
6.40
10.50
8.25
14.74
22.55
19.60
49.39
226.16
1.30
16.50
9.80
9.65
7.80
45.65
11.80
31.90
21.34
73.65
34.90
11.80
10.40
18.50
3.70
4.60
5.44
96.30
116.60
95.51
172.00
13.60
7.95
3.21
4.62
8.11
4.73
8.76
17.40
13.68
36.50
167.11
0.91
11.52
5.91
5.79
5.64
34.54
7.35
22.78
15.42
53.22
24.36
8.23
7.26
12.91
2.58
2.72
3.22
71.16
86.16
70.57
127.09
9.49
5.55
23%
28%
23%
43%
41%
23%
30%
26%
26%
30%
30%
40%
40%
28%
24%
38%
29%
28%
28%
30%
30%
30%
30%
30%
41%
41%
26%
26%
26%
26%
30%
30%
65 H 5/160/12.5N28
66 H 10/160/12.5N28
67 . 10/160 N14
68 . 5/160 N14
69 . 5/10 N30
Abdi Ibrahim
70 4.5 N1
Catalysis
71 . 10 N30 GMP
GMP
72 . 20 N30 GMP
GMP
73 .5 N50
MERCK (Germany)
74 . 100 N28
MSD (Holand)
MSD (Holand)
76 . 50/1000 N56
MSD (Holand)
77 . N40
78 - . N20
GMP
GMP
GMP
80 . 12. N10
81 . 50 N10 GMP
GMP
GMP
83 . 75 N100
Nycomed - (Germany)
84 . 150 N30
Nycomed - (Germany)
85 . 150 N100
Nycomed - (Germany)
86 . 1 N20 GMP
GMP
87 - . 300 N28
NOBEL (Tr)
GMP
89 .. .N10
90 . 2.5 N30
MERCK (Germany)
91 10 . N30
MERCK (Germany)
92 10 . N50
MERCK (Germany)
93 5 . N30
MERCK (Germany)
94 . 75/100 N30
Sanofi (France)
95 . 5 N56
Servier (France)
96 . 7.5 N56
Servier (France)
81.62
81.62
31.80
31.80
55.50
2.50
25.60
37.00
10.25
110.70
127.05
127.05
38.40
9.80
8.00
12.00
2.40
3.80
10.90
5.55
12.71
3.30
49.61
18.30
9.20
9.60
17.10
28.50
9.00
47.74
65.70
65.70
62.98
62.98
21.41
22.98
40.09
1.75
17.86
25.82
7.15
81.80
93.88
93.88
26.80
6.84
5.39
8.37
1.68
2.65
6.69
3.87
7.42
2.30
36.66
12.77
6.42
7.41
10.18
16.94
6.22
34.34
47.47
50.71
23%
23%
33%
28%
28%
30%
30%
30%
30%
26%
26%
26%
30%
30%
33%
30%
30%
30%
39%
30%
42%
30%
26%
30%
30%
23%
41%
41%
31%
28%
28%
23%
97 .200 N30
Chinoin
98 - 20/12,5 N28
MSD (Holand)
99 . 5 N28
100 . 10 N28
101 . 20 N28
102 . 25 N30
Synton
103 . 50 N30
Synthon
Remedica Ltd.
105 - . 50 N50
Berlin-chemie (Germany)
Berlin-chemie (Germany)
Chinoin
108 . 10 N100
109 . 20 N30
110 . 40 N30
KRKA (Slovenia)
KRKA (Slovenia)
KRKA (Slovenia)
Chinoin
Sanofi (France)
116 0.25% 30
Berlin-chemie (Germany)
118 50 140
Schering-Plough (Belg)
Lek
Berlin-chemie (Germany)
121 . 5 N28
Berlin-chemie (Germany)
GMP
123 . 20 N10
124 . N30
Servier (Ireland)
125 N30 .
Servier (France)
126 .N30 .
Servier (France)
127 . 5 N30
Pfizer (Germany)
128 . 10 N30
Pfizer (Germany)
10.90
7.15
49.39
52.91
104.39
110.88
135.30
117.55
4.85
8.45
6.82
142.00
85.00
90.00
26.84
8.47
25.30
15.80
15.80
15.69
3.95
35.64
84.80
26.25
15.00
10.00
9.35
40.40
22.60
33.20
13.50
20.00
6.37
4.01
38.11
37.18
75.43
81.93
99.97
86.86
3.39
5.90
4.76
104.92
62.81
66.50
20.72
4.87
19.53
9.08
9.08
10.95
2.76
23.99
62.66
18.32
9.06
6.98
6.52
28.39
15.77
22.35
9.75
13.46
42%
44%
23%
30%
28%
26%
26%
26%
30%
30%
30%
26%
26%
26%
23%
43%
23%
43%
43%
30%
30%
33%
26%
30%
40%
30%
30%
30%
30%
33%
28%
33%
129 - . 40 N100
Chinoin
130 - . 80 N24
Chinoin
Reckitt Benckiser
GMP
Astellas Pharma
134 0.25% 10
135 .N12
Farmaclair
137 .. 75 N28
Sanofi (France)
138 .. 75 N84
Sanofi (France)
139 MR . N60
Servier (France)
Servier (Ireland)
Servier (Ireland)
Servier (Ireland)
Servier (Ireland)
144 . 5 N30
Servier (France)
Servier (France)
GMP
147 . 1 N90
Aegis Ltd
148 . 2 N90
Aegis Ltd
149 .N30
KRKA (Slovenia)
Berlin-chemie (Germany)
154 0.1% 15
Famar (spain)
155 . 20 N28
KRKA (Slovenia)
156 . 40 N28
KRKA (Slovenia)
GMP
158 . . N24
Reckitt Benckiser
GMP
160 .25.N20
EGIS
11.30
7.37
8.38
3.20
42.90
1.20
2.80
8.20
31.90
52.14
28.70
33.00
33.00
40.60
40.60
21.30
28.60
13.90
46.20
74.69
5.68
14.00
14.00
11.30
12.55
8.30
40.92
59.29
11.20
8.58
4.70
5.83
6.72
5.69
5.85
2.10
19.37
0.84
1.95
5.72
18.64
38.53
19.32
23.03
23.03
28.33
28.33
14.54
20.66
9.70
34.14
55.19
3.96
9.77
9.77
7.16
7.96
5.79
30.24
43.81
7.82
5.99
3.28
4.07
41%
23%
30%
34%
55%
30%
30%
30%
42%
26%
33%
30%
30%
30%
30%
32%
28%
30%
26%
26%
30%
30%
30%
37%
37%
30%
26%
26%
30%
30%
30%
30%
161 .1.N20
Famar (Italy)
GMP
GMP
Sofarma
GMP
GMP
GMP
GMP
169 .10/2.5/10N30
Servier (Ireland)
Servier (Ireland)
171 .5/1.25/10N30
Servier (Ireland)
Servier (Ireland)
173 . 5 N28
Sanofi-Aventis (Italy)
174 600
OLIK
OLIK
Bristol-Myers(France)
Abbot (France)
Teva (Poland)
180 . 10 N28
Abdi Ibrahim
181 . 20 N28
Abdi Ibrahim
182 . 40 N28
Abdi Ibrahim
183 . 10 N28
Actavis (Malta)
184 . 5 N28
Actavis (Malta)
185 . 5 N28
EGIS
6.10
9.50
36.90
2.42
7.90
9.50
21.80
27.00
43.40
43.40
43.40
43.40
11.99
46.86
35.80
35.80
6.15
23.90
8.30
64.02
47.06
76.74
9.80
12.60
12.60
4.26
6.63
25.75
1.69
5.32
6.40
14.68
18.18
30.51
33.49
33.49
33.49
6.86
32.70
27.63
24.98
4.29
16.16
6.00
47.31
34.78
56.71
7.56
9.77
9.77
30%
30%
30%
30%
33%
33%
33%
33%
30%
23%
23%
23%
43%
30%
23%
30%
30%
32%
28%
26%
26%
26%
23%
22%
22%